We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

By LabMedica International staff writers
Posted on 18 Aug 2026

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport. More...

Point-of-care alternatives that provide immediate results without sample handling could streamline infection control, particularly when patients are most contagious. Noninvasive breath-based testing could further reduce barriers to frequent screening.

Engineers at Northeastern University have developed a handheld gas-sensing device that captures viral particles in a person’s breath and produces near-instant readouts, similar to a Breathalyzer. The platform uses a molecularly imprinted polymer (MIP), a synthetic material molded around a target molecule to form microscopic cavities that selectively capture specific viral particles, including the SARS-CoV-2 spike protein. The sensor combines a silicon base with a graphene layer; when viral particles bind to the MIP cavities, the device’s electrical resistance changes, generating a detectable signal.

The team refined the technology through multiple generations to improve sensitivity and selectivity, enabling the sensor to recognize its target biomarker while largely ignoring other volatile organic compounds in exhaled breath. The device performs best early in infection, when individuals are actively shedding virus, with performance declining as contagiousness decreases. The SARS-CoV-2 application has received a U.S. Patent and Trademark Office patent and has demonstrated high sensitivity and accuracy, although the researchers note that further testing is needed before the technology can be used for clinical diagnosis.

Because the MIP layer can be re-engineered to fit different targets, the same sensing strategy is being adapted for additional analytes. The group mentions ongoing work on sensors for disease-associated particles such as glucose for diabetes and certain RNA molecules relevant to cancer detection, as well as for substances including fentanyl. Larger-scale testing is cited as a next step before any move toward commercialization.

“It's even faster than a swab test and much more user-friendly,” said Nian Sun, distinguished professor of electrical and computer engineering at Northeastern University.

“The beauty of our sensor is that we can readily change our sensors for newly appearing or newly emerging pathogens,” added Sun.

Related Links
Northeastern University 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.